Immunotherapy Platform, MD Anderson Cancer Center
United States of America (USA)
1 December 2019 - 30 November 2020
Principal institution: The University of Texas MD Anderson Cancer Center
Region: Global
Subject/journal group: All
The table to the right includes counts of all research outputs for Immunotherapy Platform, MD Anderson Cancer Center published between 1 December 2019 - 30 November 2020 which are tracked by the Nature Index.
Hover over the donut graph to view the FC output for each subject. Below, the same research outputs are grouped by subject. Click on the subject to drill-down into a list of articles organized by journal, and then by title.
Note: Articles may be assigned to more than one subject area.
Count | Share |
---|---|
3 | 0.94 |
Outputs by subject (Share)
Subject | Count | Share | |
---|---|---|---|
Life Sciences | 3 | 0.94 |
Top articles by Altmetric score in current window
ARID1A mutation plus CXCL13 expression act as combinatorial biomarkers to predict responses to immune checkpoint therapy in mUCC
Science Translational Medicine
2020-06-17
Neoantigen responses, immune correlates, and favorable outcomes after ipilimumab treatment of patients with prostate cancer
Science Translational Medicine
2020-04-01
Immune profiling of human tumors identifies CD73 as a combinatorial target in glioblastoma
Nature Medicine
2019-12-23

Numerical information only is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.